Alzheimer's Disease Research Compendium -

Alzheimer's Disease Research Compendium

Miao-Kun Sun (Herausgeber)

Buch | Hardcover
404 Seiten
2013
Nova Science Publishers Inc (Verlag)
978-1-62257-510-7 (ISBN)
419,95 inkl. MwSt
Dementia is a brain disorder that seriously affects a person's ability to carry out daily activities. The most common form of dementia among older people is Alzheimer's Disease (AD), which involves the parts of the brain that control thought, memory, and language. Age is the most important known risk factor for AD. The number of people with the disease doubles every 5 years beyond age 65. AD is a slow disease, starting with mild memory problems and ending with severe brain damage. The course the disease takes and the speed at which changes occur vary from person to person. On average, AD patients live from 8 to 10 years after they are diagnosed, though the disease can last for as many as 20 years. Current research is aimed at understanding why AD occurs and who is at greatest risk of developing it, improving the accuracy of diagnosis and the ability to identify those at risk, discovering, developing, and testing new treatments, and discovering treatments for behavioural problems in patients with AD. This book presents the latest research in the field.

Miao-Kun Sun, Ph.D. obtained his Ph.D. at the Department of Pharmacology, University of Virginia, in 1986, and continued postdoctoral research at the same department for two more years. After a brief research period (one year) at the Department of Physiology, Royal Free Hospital School of Medicine, University College of London, he accepted a faculty position at Department of Neurology and Neuroscience, Cornell University Medical College in New York in 1990. His current position is Professor at Blanchette Rockefeller Neurosciences Institute (holding the same position since 2000).

Preface; SSAO & A in Vascular Damage in the Temporal Cortex From Alzheimer & Alzheimer With Diabetes Patients; Amyloid Precursor Protein in Central & Peripheral Cholinergic Synaptopathies; In Vivo Analysis Using a Presenilin-1-Specific Inhibitor: Presenilin1-Containing -Secretase Complexes Mediate the Majority of CNS A Production in the Mouse; Insight Into Synaptopathy in Alzheimers Disease: From Lifestyle to PS1/N-Cadherin Interaction; Interaction & Stimulation Through a Computer: A Program Specially Designed for Mild to Moderate Alzheimer's Patients; Novel Therapies for Alzheimer's Disease: Potentially Disease Modifying Drugs.

Verlagsort New York
Sprache englisch
Maße 180 x 260 mm
Gewicht 938 g
Themenwelt Medizin / Pharmazie Medizinische Fachgebiete Geriatrie
ISBN-10 1-62257-510-5 / 1622575105
ISBN-13 978-1-62257-510-7 / 9781622575107
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich

von Gisela Mötzing; Susanna Schwarz

Buch | Softcover (2022)
Urban & Fischer in Elsevier (Verlag)
33,00
das gesamte Spektrum der Altersmedizin für Klinik und Praxis

von Jürgen M. Bauer; Clemens Becker; Michael Denkinger

Buch | Hardcover (2024)
Kohlhammer (Verlag)
189,00
Das Wichtigste für Ärztinnen und Ärzte aller Fachrichtungen

von Klaus Hager; Olaf Krause

Buch | Softcover (2021)
Urban & Fischer in Elsevier (Verlag)
37,00